We have observed
6 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 12, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
POLYINOSINIC-POLYCYTIDYLIC ACID (POLY(I:C)) PEA STARCH FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS
HETEROCYCLIC INDOLES FOR USE IN INFLUENZA VIRUS INFECTION
FUNCTIONALIZED PENTANOIC ACIDS FOR USE IN INFLUENZA VIRAL INFECTIONS